Usefulness and tolerability of Hirulog, a direct thrombin-inhibitor, in unstable angina pectoris
- 1 December 1993
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (18), 1357-1360
- https://doi.org/10.1016/0002-9149(93)90179-g
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.Circulation, 1993
- Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery diseaseThe American Journal of Cardiology, 1993
- Randomized trial of thrombolysis versus heparin in unstable angina.Circulation, 1992
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombinBiochemistry, 1990